Skip to main content

The European Journal of Health Economics

Ausgabe 5/2019

Inhalt (12 Artikel)

Editorial

Conflict of interest disclosure: striking a balance?

Livio Garattini, Anna Padula

Original Paper

A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients

Carlos King Ho Wong, Prudence Wing Hang Cheung, Nan Luo, Jason Pui Yin Cheung

Open Access Original Paper

Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data

François-Olivier Baudot, Anne-Sophie Aguadé, Thomas Barnay, Christelle Gastaldi-Ménager, Anne Fagot-Campagna

Original Paper

Hiring subsidies for people with a disability: do they work?

Sergi Jiménez-Martín, Arnau Juanmartí Mestres, Judit Vall Castelló

Original Paper

Catastrophic long-term care expenditure: associated socio-demographic and economic factors

Raúl del Pozo-Rubio, Román Mínguez-Salido, Isabel Pardo-García, Francisco Escribano-Sotos

Original Paper

Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study)

Maria Rubio-Valera, María Teresa Peñarrubia-María, Maria Iglesias-González, Martin Knapp, Paul McCrone, Marta Roig, Ramón Sabes-Figuera, Juan V. Luciano, Juan M. Mendive, Ana Gabriela Murrugara-Centurión, Jordi Alonso, Antoni Serrano-Blanco

Open Access Original Paper

Demand-side determinants of rising hospital admissions in Germany: the role of ageing

Jonas Krämer, Jonas Schreyögg

Original Paper

The weekend effect revisited: evidence from the Upper Austrian stroke registry

Silvia Angerer, Klaus Buttinger, Harald Stummer

Original Paper

Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer

Dirk Müller, Marion Danner, Rita Schmutzler, Christoph Engel, Kirsten Wassermann, Björn Stollenwerk, Stephanie Stock, Kerstin Rhiem

Open Access Original Paper

Estimating the marginal cost of a life year in Sweden’s public healthcare sector

Jonathan Siverskog, Martin Henriksson

Original Paper

A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer

Cuc Thi Thu Nguyen, Fabio Petrelli, Stefania Scuri, Binh Thanh Nguyen, Iolanda Grappasonni